“PLCE1 Is a Poor Prognostic Marker and May Promote Immune Escape from Osteosarcoma by the CD70-CD27 Signaling Pathway”. 2022. Biomolecules and Biomedicine 22 (6): 992-1004. https://doi.org/10.17305/bjbms.2022.7416.